Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV Vaccination and Cervical Cancer Screening in Kenya (MISP2)
NCT04774887Completed
- Sponsor
- Indiana University
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of qHPV vaccine in human papillomavirus infection, sponsored by Indiana University. Primary endpoints: Detection of high-grade cervical intraepithelial neoplasia (CIN) 2/3+ at 2 years and Seroconversion to all HPV vaccine types at 2 years. Started Nov 2021; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT04774887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04774887.